163 related articles for article (PubMed ID: 22574676)
1. Novel medication targets for the treatment of alcoholism: preclinical studies.
Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic receptor system as a target for treating alcohol abuse and dependence.
Rahman S; Prendergast MA
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):145-50. PubMed ID: 22574675
[TBL] [Abstract][Full Text] [Related]
3. Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.
Bell RL; Franklin KM; Hauser SR; Zhou FC
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):93-112. PubMed ID: 22574678
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine-A.
Touchette JC; Moen JK; Robinson JM; Lee AM
Addict Biol; 2021 Mar; 26(2):e12908. PubMed ID: 32329567
[TBL] [Abstract][Full Text] [Related]
5. Carisbamate, a novel antiepileptic candidate compound, attenuates alcohol intake in alcohol-preferring rats.
Rezvani AH; Overstreet DH; Vaidya AH; Zhao B; Levin ED
Alcohol Clin Exp Res; 2009 Aug; 33(8):1366-73. PubMed ID: 19413647
[TBL] [Abstract][Full Text] [Related]
6. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
7. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
[TBL] [Abstract][Full Text] [Related]
8. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.
Cowen MS; Adams C; Kraehenbuehl T; Vengeliene V; Lawrence AJ
Addict Biol; 2005 Sep; 10(3):233-42. PubMed ID: 16109584
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapies for alcoholism: the old and the new.
Olive MF
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism.
Tizabi Y; Getachew B; Rezvani AH; Hauser SR; Overstreet DH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):398-402. PubMed ID: 18835320
[TBL] [Abstract][Full Text] [Related]
11. JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats.
Galici R; Rezvani AH; Aluisio L; Lord B; Levin ED; Fraser I; Boggs J; Welty N; Shoblock JR; Motley ST; Letavic MA; Carruthers NI; Dugovic C; Lovenberg TW; Bonaventure P
Psychopharmacology (Berl); 2011 Apr; 214(4):829-41. PubMed ID: 21086115
[TBL] [Abstract][Full Text] [Related]
12. Medications and alcohol craving.
Swift RM
Alcohol Res Health; 1999; 23(3):207-13. PubMed ID: 10890816
[TBL] [Abstract][Full Text] [Related]
13. Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.
Overstreet DH; Rezvani AH; Cowen M; Chen F; Lawrence AJ
Addict Biol; 2006 Sep; 11(3-4):356-73. PubMed ID: 16961764
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of alcohol dependence: a review of the evidence.
Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
[TBL] [Abstract][Full Text] [Related]
15. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
Rezvani AH; Overstreet DH; Levin ED; Rosenthal DI; Kordik CP; Reitz AB; Vaidya AH
Alcohol Clin Exp Res; 2007 Jan; 31(1):57-63. PubMed ID: 17207102
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Heilig M; Egli M
Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
[TBL] [Abstract][Full Text] [Related]
17. Treatment of alcohol dependence: recent progress and reduction of consumption.
Testino G; Leone S; Borro P
Minerva Med; 2014 Dec; 105(6):447-66. PubMed ID: 25392958
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
Soyka M; Müller CA
Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of alcohol dependence: a review of the clinical data.
Mann K
CNS Drugs; 2004; 18(8):485-504. PubMed ID: 15182219
[TBL] [Abstract][Full Text] [Related]
20. Drugs for relapse prevention of alcoholism: ten years of progress.
Spanagel R; Kiefer F
Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
